Castle Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.8% | -6.7% | +208.1% | -23.8% | +23.2% | +37.6% | +19.4% | -1.2% | -27.0% | +19.7% | +13.7% | +31.9% | -0.2% | +3.2% | +6.7% | +7.2% | +29.7% | +6.2% | +3.6% | +9.6% | +19.3% | +22.6% | +7.5% | +10.4% | +19.2% | -1.4% | +0.6% | +1.9% | -2.0% | -3.6% | +4.8% | -3.8% | +23.7% | – | |
| – | +5.9% | +1.8% | +1.1% | +17.0% | +24.7% | -14.3% | +17.7% | +18.9% | -10.2% | +15.3% | +8.0% | +13.3% | +22.1% | +21.7% | +2.2% | +29.3% | +29.3% | +15.3% | +7.5% | +7.0% | +8.6% | +2.4% | +9.8% | +11.8% | +4.5% | +7.5% | +3.7% | +1.2% | +7.6% | +6.1% | -2.1% | +12.1% | +15.4% | – | |
| – | +10.3% | -11.0% | +326.5% | -29.3% | +22.9% | +49.4% | +19.6% | -3.8% | -29.7% | +20.6% | +14.8% | +35.3% | -3.7% | -0.5% | +7.7% | +2.3% | +29.9% | +3.7% | +2.4% | +10.5% | +22.7% | +28.4% | +7.0% | +10.0% | +22.7% | -3.2% | -0.1% | +2.1% | -4.2% | -6.2% | +6.8% | -8.1% | +26.4% | – | |
| – | -8.2% | +11.7% | -12.1% | +22.5% | -5.5% | +15.0% | +108.5% | -7.8% | -7.2% | +13.1% | +49.8% | +29.0% | +15.0% | +10.4% | +25.9% | +13.9% | +10.8% | -8.5% | +3.7% | +27.3% | -7.5% | -2.9% | +0.5% | +6.3% | +2.4% | -12.8% | -5.2% | +7.8% | +1.6% | +1.4% | +4.3% | +6.8% | +0.8% | – | |
| – | -1.6% | -5.8% | +4.2% | +48.0% | +12.8% | +4.4% | +38.3% | +12.4% | -6.2% | +12.6% | +27.8% | +0.0% | -40.1% | +4.5% | +169.0% | -51.4% | +30.1% | -10.5% | +111.8% | -44.2% | -2.3% | -1.9% | +6.2% | +4.8% | +2.6% | +12.2% | -5.4% | +11.6% | +5.2% | +0.8% | +0.9% | +2.3% | +5.6% | – | |
| – | -3.1% | -2.0% | +1.7% | +40.3% | +9.4% | +6.1% | +50.6% | +7.5% | -19.8% | +48.4% | +6.1% | +36.3% | +15.8% | +10.5% | +15.7% | +27.5% | +13.4% | -3.6% | +3.9% | +22.7% | -5.0% | -0.7% | -0.8% | +8.8% | +4.5% | -3.5% | +1.5% | +50.6% | -26.8% | -2.3% | +1.9% | +12.5% | +1.7% | – | |
| – | – | – | – | -106.7% | – | +628.9% | -41.0% | -60.3% | -162.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1.3% | -20.3% | -789.6% | – | – | – | – | – | – | |
| – | -1.0% | +8.4% | +14.3% | +57.6% | +65.2% | -35.7% | -29.6% | -0.2% | +0.7% | -8.2% | -44.1% | -99.0% | +500.0% | -4.2% | -95.7% | +200.0% | +33.3% | +50.0% | -33.3% | +0.0% | -25.0% | -33.3% | +0.0% | +600.0% | +1,828.6% | -25.6% | -54.2% | -81.5% | +23.5% | +14.3% | +0.0% | +458.3% | +44.0% | – | |
| – | – | – | – | -135.0% | – | – | -63.6% | -73.2% | -341.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +5.0% | -4.8% | -433.2% | – | – | – | – | – | – | |
| – | +9.7% | -5.9% | -98.4% | +11,420.7% | +100,323.1% | -69.2% | -100.0% | +313.9% | -87.2% | -52.6% | +366.7% | -95.2% | +25.0% | +360.0% | -38,034.8% | – | -1,560.4% | – | – | -75.4% | +14.3% | +100.0% | +21.9% | +15.4% | -2,397.8% | – | -128.4% | – | – | – | -432.2% | – | +239.4% | – | |
| – | – | – | – | -135.1% | – | – | -64.9% | -72.3% | -341.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -74.6% | +322.7% | -369.5% | – | -111.1% | – | – | – | – | |
| – | – | – | – | -105.5% | – | +1,275.3% | -57.4% | -52.4% | -135.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +26.3% | +1,229.9% | +4.5% | +14.3% | -74.5% | -6.2% | +4.9% | -68.5% | -1,052.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.